HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juan P Casas Selected Research

Pneumonia (Pneumonitis)

3/2014Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juan P Casas Research Topics

Disease

20Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2005
15Coronary Disease (Coronary Heart Disease)
10/2020 - 04/2008
9Pre-Eclampsia (Preeclampsia)
09/2020 - 02/2004
8Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2008
8Stroke (Strokes)
10/2020 - 01/2005
6COVID-19
01/2022 - 07/2020
6Ischemic Stroke
01/2022 - 11/2004
4Neoplasms (Cancer)
01/2020 - 12/2009
4Inflammation (Inflammations)
04/2013 - 03/2008
3Myocardial Infarction
01/2022 - 01/2020
2Infections
01/2022 - 09/2020
2Dementia (Dementias)
01/2020 - 03/2014
2Abdominal Aortic Aneurysm
01/2020 - 12/2013
2Heart Failure
01/2020 - 06/2006
2Diabetes Mellitus
01/2020 - 01/2013
2Coronary Artery Disease (Coronary Atherosclerosis)
06/2017 - 06/2010
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
06/2017 - 10/2014
2Obesity
02/2016 - 01/2013
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022
1Kidney Diseases (Kidney Disease)
01/2022
1Respiratory Insufficiency (Respiratory Failure)
07/2020
1Genetic Risk Score
01/2020
1ST Elevation Myocardial Infarction
01/2020
1Heart Injuries
01/2020
1HELLP Syndrome
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Peripheral Arterial Disease
01/2020
1Pulmonary Hypertension
01/2018
1Communicable Diseases (Infectious Diseases)
06/2016
1Bacteremia
06/2016
1Morbid Obesity
02/2016
1Arthritis (Polyarthritis)
03/2014
1Pneumonia (Pneumonitis)
03/2014
1Eye Diseases (Eye Disease)
03/2014
1Embolism (Embolus)
03/2014
1Muscular Diseases (Myopathy)
03/2014
1Cognitive Dysfunction
03/2014
1Acute Coronary Syndrome
11/2013

Drug/Important Bio-Agent (IBA)

10C-Reactive ProteinIBA
09/2020 - 06/2006
8Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2008
7LipidsIBA
01/2021 - 02/2012
6Proteins (Proteins, Gene)FDA Link
02/2021 - 08/2017
5Triglycerides (Triacylglycerol)IBA
01/2021 - 10/2014
5Interleukin-6 (Interleukin 6)IBA
09/2020 - 04/2005
5ORALIT (ORS)IBA
10/2019 - 11/2004
5ApolipoproteinsIBA
01/2018 - 11/2004
4oxidized low density lipoproteinIBA
10/2020 - 04/2013
4Apolipoproteins E (ApoE)IBA
01/2018 - 04/2007
3Pharmaceutical PreparationsIBA
01/2021 - 10/2019
3LDL CholesterolIBA
10/2020 - 04/2017
3Lipoproteins (Lipoprotein)IBA
10/2020 - 06/2010
3Antihypertensive Agents (Antihypertensives)IBA
01/2020 - 12/2005
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2019 - 01/2013
3HomocysteineIBA
01/2018 - 01/2005
3Phospholipases (Phospholipase)IBA
03/2014 - 06/2010
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2007 - 11/2004
3Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2006 - 03/2004
22019-nCoV Vaccine mRNA-1273IBA
01/2022 - 01/2022
2BNT162 VaccineIBA
01/2022 - 01/2022
2VaccinesIBA
01/2022 - 01/2022
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2019 - 12/2005
2Monoclonal AntibodiesIBA
01/2018 - 04/2017
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2018 - 08/2011
2HDL CholesterolIBA
03/2015 - 01/2013
2Fibrinogen (Factor I)FDA Link
10/2014 - 11/2011
2EnzymesIBA
03/2014 - 12/2011
2Complement Factor H (Factor H)IBA
02/2012 - 11/2010
1P-2 (P 2)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Apolipoprotein L1IBA
01/2022
1tocilizumab (atlizumab)FDA Link
01/2020
1Troponin T (Troponin T1)IBA
01/2020
1Therapeutic UsesIBA
01/2020
1Angiotensin Receptor AntagonistsIBA
12/2019
111-dehydro-thromboxane B2IBA
12/2019
1Indicators and Reagents (Reagents)IBA
12/2019
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2018
1Apolipoproteins B (ApoB)IBA
01/2018
1Biological ProductsIBA
08/2017
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
08/2017
1Protein Isoforms (Isoforms)IBA
08/2017
1PCSK9 InhibitorsIBA
04/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2017
1Untranslated RNA (Noncoding RNA)IBA
06/2016
1Long Noncoding RNAIBA
06/2016
1Uric Acid (Urate)IBA
04/2016
1LeptinIBA
02/2016
1Urea (Carbamide)FDA LinkGeneric
10/2014
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
10/2014
1CholesterolIBA
10/2014
1Factor VII (Proconvertin)IBA
10/2014
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
07/2014
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
12/2013
1Secretory Phospholipases A2IBA
11/2013
1IsoenzymesIBA
11/2013
1CytokinesIBA
04/2013

Therapy/Procedure

6Therapeutics
01/2021 - 06/2006
4Secondary Prevention
11/2018 - 04/2017
2Drug Therapy (Chemotherapy)
04/2017 - 12/2009
1Endarterectomy (Thromboendarterectomy)
01/2018